Zofia Hélias‐Rodzewicz

High prevalence of BRAF V600E mutations in Erdheim-Chester disease but not in other non-Langerhans cell histiocytoses

Julien Haroche, Frédéric Charlotte, Laurent Arnaud et al. · Blood · 2012 · 693 citations

Medicine, Genetics, Molecular Genetics +10

<i>BRAF</i> Mutation Correlates With High-Risk Langerhans Cell Histiocytosis and Increased Resistance to First-Line Therapy

Sébastien Héritier, Jean‐François Emile, Mohamed‐Aziz Barkaoui et al. · Journal of Clinical Oncology · 2016 · 335 citations · Full text

Medicine, Oncology, Pathology +12

Recurrent RAS and PIK3CA mutations in Erdheim-Chester disease

Jean‐François Emile, Eli L. Diamond, Zofia Hélias‐Rodzewicz et al. · Blood · 2014 · 244 citations · Full text

Medicine, Genetics, Molecular Genetics +14

Vemurafenib for Refractory Multisystem Langerhans Cell Histiocytosis in Children: An International Observational Study

Jean Donadieu, Islam Amine Larabi, M. Tardieu et al. · Journal of Clinical Oncology · 2019 · 220 citations · Full text

Medicine, Oncology, Pediatrics +13

Predictive role of plasmatic biomarkers in advanced non-small cell lung cancer treated by nivolumab

Adrien Costantini, Catherine Julié, Coraline Duménil et al. · OncoImmunology · 2018 · 173 citations · Full text

Medicine, Immunology, Oncology +17